Tenaya Therapeutics, Inc. Common Stock

TNYANASDAQ • USD
ThemeGenomics & Precision Med.›Gene Therapy & Gene Editing
0.41 USD
↗ 0.02 (5.04%)AT CLOSE (03:59 PM EDT)
0.41
↗ 0.00 (0.83%)
POST MARKET (AS OF 07:55 PM EDT)
Post Market
AS OF 07:55 PM EDT
0.41
↗ 0.00 (0.83%)
🔴Market: CLOSED

Tenaya Therapeutics, Inc. Common Stock (TNYA) trades at $0.41 per share. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Sell". Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. TNYA is fairly valued relative to its sector peers based on current multiples.

Technical & fundamental data as of Oct 26, 2026.

Open?$0.39
High?$0.42
Low?$0.39
Prev. Close?$0.39
Volume?3.4M
Avg. Volume?3.7M
VWAP?$0.41
Rel. Volume?0.93x
Bid / Ask
Bid?$0.34 × 100
Ask?$0.48 × 100
Spread?$0.14
Midpoint?$0.41
Valuation & Ratios
Market Cap?87.4M
Shares Out?224.2M
Float?172.3M
Float %?76.8%
P/E Ratio?N/A
P/B Ratio?1.26
EPS?-$0.46
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Tenaya Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of therapies targeting the underlying mechanisms of heart disease. It is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine. The company's clinical-stage gene therapy candidates include TN-201 and TN-401. It operates in one operating segment, which is the business of discovering and developing potential treatments that address the underlying drivers of heart disease.
Themes
Healthcare - Genomics & Precision Medicine›Gene Therapy & Gene EditingBiotech - Drug Development›Rare Disease Therapeutics
Employees
70
Market Cap
87.2M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
www.tenayatherapeutics.com
Listed
2021-07-30
Address
171 OYSTER POINT BLVD., SUITE 500
SOUTH SAN FRANCISCO, CA 94080
Phone: 415-865-2066
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
85
Short Sent.?
40
Piotroski F-Score?0/9Weak
Altman Z-Score?-10.63Distress
Confidence?43%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?13.07%High
Short Interest?22.5M
Days to Cover?4.6
Free Float172.3M
Avg Daily Volume4.9M
Settlement Date2026-10-15
Financial Health
Current Ratio?4.52Strong
Quick Ratio?4.52Strong
Cash Ratio?4.11Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
92
1.26CHEAP▾
P/S?
Peers
100
S&P
3
65.51HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-0.1CHEAP▾
EV/Sales?
Peers
100
S&P
20
7.01HIGH▾
Returns & Efficiency
ROE?
S&P
3
-148.6%WEAK▾
ROA?
S&P
3
-110.2%WEAK▾
Cash Flow & Enterprise
FCF?$-52588000
Enterprise Value?$9.4M
Fundamentals ratios updated end of day
MarketsMoversWatchlist